Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery.
Michal Fried, Jonathan D Kurtis, Bruce Swihart...
https://pubmed.ncbi.nlm.nih.gov/29020221/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-26
15000
Participants Needed
2
Research Sites
N/A
Total Duration
Malaria caused by Plasmodium falciparum remains a serious global health problem, particularly affecting pregnant women and young children. This research aims to understand the immune and parasite factors linked to infection and disease in these groups. The study focuses on how pregnancy malaria leads to complications like low birth weight, anemia, and hypertension, and how early life exposure influences the risk of severe childhood malaria. Researchers hypothesize that parasites causing severe childhood malaria might have unique characteristics. The study is a long-term observational cohort conducted in Mali, involving up to 2000 pregnant women and their infants, 2000 children aged 0-3 years followed to age 5, as well as up to 3000 febrile children up to 10 years old. Additionally, 500 pregnant women are enrolled for a case-control study on pregnancy malaria and preeclampsia. About 1000 children from the original birth cohort are re-enrolled and followed for up to 10 years into adolescence and early adulthood. Participants receive clinical evaluations and blood sampling at various intervals throughout the study. Participants undergo regular clinical, parasitologic, and immune system assessments, with blood samples collected periodically. Hospitalized and non-hospitalized febrile children also provide acute and recovery samples. Researchers analyze these data to identify factors linked to malaria infection and disease outcomes in pregnant women and children. The study includes long-term follow-up of children into early adulthood to understand disease susceptibility over time.
CONDITIONS
Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
M
Michal Fried, Ph.D.
P
Patrick E Duffy, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 years depending on cohort
Participants undergo regular clinical evaluations and blood sample collections to monitor malaria infection and immune responses over time.
Periodic visits for clinical check-ups and sample collection
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Michal Fried, Jonathan D Kurtis, Bruce Swihart...
https://pubmed.ncbi.nlm.nih.gov/29020221/Atis Muehlenbachs, Theonest K Mutabingwa, Sally Edmonds...
https://pubmed.ncbi.nlm.nih.gov/17105340/Justin Y A Doritchamou, Jonathan P Renn, Bethany Jenkins...
https://pubmed.ncbi.nlm.nih.gov/35103596/M Fried, F Nosten, A Brockman...
https://pubmed.ncbi.nlm.nih.gov/9804416/Almahamoudou Mahamar, Patricia A Gonzales Hurtado, Robert Morrison...
https://pubmed.ncbi.nlm.nih.gov/34871370/Almahamoudou Mahamar, Naissem Andemel, Bruce Swihart...
https://pubmed.ncbi.nlm.nih.gov/33846719/M Ho, B Singh, S Looareesuwan...
https://pubmed.ncbi.nlm.nih.gov/1997437/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor